BrightSpring Health (BTSG) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.45
- EPS estimate
- $0.40
- EPS surprise
- +13.55%
- Revenue surprise
- +5.80%
- Revenue
- $3.9B
- Revenue estimate
- $3.7B
- Reported
- Jul 31, 2026
BrightSpring Health reported Q2 2026 results on July 31, 2026. Earnings per share were $0.45, ahead of the $0.40 estimate by 13.55%. Revenue was $3.9 billion against a $3.7 billion consensus, a beat of 5.80%. Compared with Q2 2025, EPS rose about 105% from $0.22 and revenue rose about 26% from $3.1 billion. Both were the highest in the table.
The record is fairly short, with 11 quarters starting from Q4 2023. That first quarter was a loss of $0.06 per share. Every quarter since has been profitable. Annual EPS was $0.55 in 2024 and $1.04 in 2025, up about 89%. The first half of 2026 adds up to $0.84, about double the $0.41 of the first half of 2025. Revenue rose from $2.4 billion in Q4 2023 to $3.9 billion. BrightSpring beat the EPS estimate in seven of the 11 quarters. The most recent miss was Q4 2025, at 3.85% below.
Q3 results came on November 1, 2024 and October 20, 2025, the only two third-quarter reports in the table. That points to late October or early November 2026 for the next report. It will show whether the year-over-year growth of the first half carries into the third quarter.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 31, 2026 | $0.40 | $0.45 | +13.55% | $3.9B | SEC |
| Q1 2026 | May 1, 2026 | $0.31 | $0.39 | +26.25% | $3.6B | SEC |
| Q4 2025 | Feb 27, 2026 | $0.34 | $0.33 | −3.85% | $3.6B | SEC |
| Q3 2025 | Oct 20, 2025 | $0.25 | $0.30 | +21.07% | $3.3B | SEC |
| Q2 2025 | Aug 1, 2025 | $0.19 | $0.22 | +17.58% | $3.1B | SEC |
| Q1 2025 | May 2, 2025 | $0.09 | $0.19 | +108.79% | $2.9B | SEC |
| Q4 2024 | Mar 6, 2025 | $0.21 | $0.22 | +3.82% | $3.1B | SEC |
| Q3 2024 | Nov 1, 2024 | $0.15 | $0.11 | −28.53% | $2.9B | SEC |
| Q2 2024 | Aug 2, 2024 | $0.13 | $0.10 | −25.87% | $2.7B | SEC |
| Q1 2024 | May 2, 2024 | $0.04 | $0.12 | +220.00% | $2.6B | SEC |
| Q4 2023 | Feb 29, 2024 | $0.10 | −$0.06 | −157.42% | $2.4B | SEC |
Quarterly revenue
Frequently asked questions
When did BrightSpring Health (BTSG) last report earnings?
BrightSpring Health last reported on Jul 31, 2026, covering fiscal Q2 2026.
Did BTSG beat earnings estimates?
Yes. BrightSpring Health reported EPS of $0.45 for Q2 2026 against a $0.40 estimate — a 13.55% beat.
How much revenue did BTSG report last quarter?
BrightSpring Health reported $3.9B in revenue for Q2 2026, against a consensus estimate of $3.7B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.